Clin2
NCT07139535Likely a fitNot yet recruiting

Study of RAY1225 for type 2 diabetes not on medication

T2DM

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a new medicine called RAY1225 for people with type 2 diabetes who are not on diabetes drugs. It aims to see if the medicine can help control blood sugar and weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
350 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with type 2 diabetes.
  • You are not currently on any diabetes medication, or you stopped taking them more than 12 weeks ago.
  • Your body mass index (BMI) is 20 or higher.
  • Your weight has been steady (no more than 5% change) for the last 12 weeks.
  • You do not have type 1 diabetes or severe diabetes eye complications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139548Not yet recruiting· Phase 3
Comparing a new diabetes drug to semaglutide

This study tests a new medication, RAY1225, against a standard treatment (semaglutide) for people with type 2 diabetes who already take oral diabetes pills. It aims to see if RAY1225 can help manage blood sugar better.

Beijing, Heibei
NCT07527650Recruiting· Phase 2
Testing HM15275 for Type 2 Diabetes Management

This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.

Mesa, Arizona
NCT07599410Recruiting· Phase 2
Testing HRS9531 for Type 2 Diabetes Blood Sugar Control

This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.

Beijing, Beijing Municipality
NCT06254261Recruiting· Phase 2
RAY1225 for weight loss in obesity

This study tests an investigational medication called RAY1225 in people with obesity. It's given as an injection and may help with weight loss by targeting hormones that control appetite.

Beijingcun, Hebei
NCT06893016Recruiting· Phase 3
Study of RAY1225 for adults with obesity or overweight

This trial tests a new medicine called RAY1225 to help people lose weight. If you have obesity or are overweight with related health conditions, you may be able to join.

Beijing
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing

Hear when a new T2DM trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.